Our results demonstrate that salicylate treatment of hepatocytes infected with rodent and human malaria parasites results in reduced parasite replication, which was also shown in vivo with P. berghei and is consistent with the effect of overexpressing a constitutively active AMPK in vitro. This evidence concerns the gene PRKAA2 and malaria.